Officials at Agea Medical said it is closing in on an $8 million funding round.

The Redwood City, Calif.-based medical device company has raised $6 million for its coffers and is close to its goal.

Agea markets a system that uses vapor to ablate uterine cavity tissues. The company develops medical technology to treat excessive menstrual bleeding, a condition the company says impacts 1 in 4 women in the U.S.